NCT00621179View on ClinicalTrials.gov

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

January 31, 2010

Conditions
EndometriosisInfertility
Interventions
DRUG

Leuprolide acetate in depot suspension

Leuprolide acetate in depot suspension 3.75 mg intramuscularly every 28 days x 3

OTHER

No intervention

Trial Locations (1)

80124

Colorado Center for Reproductive Medicine, Lone Tree

All Listed Sponsors
lead

Colorado Center for Reproductive Medicine

OTHER

NCT00621179 - Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF | Biotech Hunter | Biotech Hunter